Orchard Therapeutics closes $150 million Series C round
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.
At the MedCity INVEST conference in Chicago last week, panelists shared insights on what companies need to consider for what can be a complicated pathway to reimbursement.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.